glp-1 drugs pill form Weight-Loss Study Compares Effectiveness to Injectables New GLP-1 drugs could suppress

The warning also notes that serious neuropsychiatric issues linked to bupropion have been reported

The body weight loss observed in this study opens perspectives for a pharmacological treatment of obesity as an alternative to various procedures of bariatric surgery

Similar findings have been reported for GLP-1 treatment of type-1 diabetes [623] but GLP-1 improvement of endothelial function seems to be related to native GLP-1 and is not observed when GLP-1R agonists are compared head-to-head with equally glucose lowering medications

Even people who achieve the treatment goals with the new obesity pharmacotherapies might decide to undergo bariatric surgery to support long-term weight maintenance because either they experience weight regain on the medication or they do not have long-term access to obesity pharmacotherapy, or they prefer not to take obesity pharmacotherapy lifelong

In: StatPearls

That has not been borne out in any of the follow-up data, he said